CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Activity

20 hedge funds and large institutions have $3.85M invested in Cellectar Biosciences in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 5 closing their positions.

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACP
1
Acuta Capital Partners
California
$320K
2
Geode Capital Management
2
Geode Capital Management
Massachusetts
$166K
3
CB
3
Commerce Bank
Missouri
$31.7K
4
Wealth Enhancement Advisory Services
4
Wealth Enhancement Advisory Services
Minnesota
$31.7K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$464K

Top Sellers

1
ACM
1
AIGH Capital Management
Maryland
$1.79M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$57K
3
WVP
3
Worth Venture Partners
New Jersey
$737K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
MS
5
Maven Securities
Jersey
$0
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
– – – –
1
2